These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 6958353)

  • 1. Candida infections in patients with acute leukemia: ineffectiveness of nystatin prophylaxis and relationship between oropharyngeal and systemic candidiasis.
    DeGregorio MW; Lee WM; Ries CA
    Cancer; 1982 Dec; 50(12):2780-4. PubMed ID: 6958353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral anticandidal prophylaxis in patients undergoing chemotherapy for acut- leukemia.
    Williams C; Whitehouse JM; Lister TA; Wrigley PF
    Med Pediatr Oncol; 1977; 3(3):275-80. PubMed ID: 311410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of nystatin in prevention and elimination of oropharyngeal Candida in immunosuppressed patients.
    Barrett AP
    Oral Surg Oral Med Oral Pathol; 1984 Aug; 58(2):148-51. PubMed ID: 6592508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral candidiasis in hematopoietic cell transplantation patients: an outcome-based analysis.
    Epstein JB; Hancock PJ; Nantel S
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Aug; 96(2):154-63. PubMed ID: 12931087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative trial of oral clotrimazole and nystatin for oropharyngeal candidiasis prophylaxis in orthotopic liver transplant patients.
    Ruskin JD; Wood RP; Bailey MR; Whitmore CK; Shaw BW
    Oral Surg Oral Med Oral Pathol; 1992 Nov; 74(5):567-71. PubMed ID: 1437059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nystatin prophylaxis in leukemia and lymphoma.
    Williams CJ
    N Engl J Med; 1978 Apr; 298(15):853. PubMed ID: 634322
    [No Abstract]   [Full Text] [Related]  

  • 7. Oral nystatin prophylaxis to prevent invasive candidiasis in Neonatal Intensive Care Unit.
    Ozturk MA; Gunes T; Koklu E; Cetin N; Koc N
    Mycoses; 2006 Nov; 49(6):484-92. PubMed ID: 17022766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical polyene antifungals in hematopoietic cell transplant patients: tolerability and efficacy.
    Epstein JB; Truelove EL; Hanson-Huggins K; Mancl LA; Chen A; Press OW; Petersdorf SH; Fritsche TR; Epstein JD
    Support Care Cancer; 2004 Jul; 12(7):517-25. PubMed ID: 15108100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A reevaluation of nystatin in prophylaxis and treatment of oropharyngeal candidiasis.
    Alvarez Alvarez ME; Sánchez-Sousa A; Baquero F
    Rev Esp Quimioter; 1998 Dec; 11(4):295-315. PubMed ID: 9990144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral nystatin prophylaxis of Candida spp. colonization in ventilated critically ill patients.
    Normand S; François B; Dardé ML; Bouteille B; Bonnivard M; Preux PM; Gastinne H; Vignon P
    Intensive Care Med; 2005 Nov; 31(11):1508-13. PubMed ID: 16195905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nystatin prophylaxis in immunocompromised children.
    Taylor TL
    Ann Pharmacother; 1996 May; 30(5):534-5. PubMed ID: 8740337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nystatin prophylaxis in leukemia and lymphoma.
    Pizzuto J; Conte G; Avilés A; Ambríz R; Morales M
    N Engl J Med; 1978 Sep; 299(12):661-2. PubMed ID: 683243
    [No Abstract]   [Full Text] [Related]  

  • 13. A double-blind comparison of fluconazole and nystatin in the prevention of candidiasis in patients with leukaemia. Antifungal Prophylaxis Study Group.
    Young GA; Bosly A; Gibbs DL; Durrant S
    Eur J Cancer; 1999 Aug; 35(8):1208-13. PubMed ID: 10615231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluconazole versus nystatin in the prevention of candida infections in children and adolescents undergoing remission induction or consolidation chemotherapy for cancer.
    Groll AH; Just-Nuebling G; Kurz M; Mueller C; Nowak-Goettl U; Schwabe D; Shah PM; Kornhuber B
    J Antimicrob Chemother; 1997 Dec; 40(6):855-62. PubMed ID: 9462438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review of the effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients.
    Patton LL; Bonito AJ; Shugars DA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):170-9. PubMed ID: 11505264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral and gastrointestinal candidosis: prophylaxis during immunosuppressive therapy.
    Prentice AG
    Mycoses; 1989; 32 Suppl 2():42-6. PubMed ID: 2700221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candida infection with and without nystatin prophylaxis. A 11-year experience with patients with burn injury.
    Desai MH; Rutan RL; Heggers JP; Herndon DN
    Arch Surg; 1992 Feb; 127(2):159-62. PubMed ID: 1540092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial comparing ketoconazole and nystatin prophylactic therapy in neutropenic patients.
    Vogler WR; Malcom LG; Winton EF
    Cancer Invest; 1987; 5(4):267-73. PubMed ID: 3664330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of antifungal prophylaxis with antifungal drugs against oropharyngeal candidiasis in cancer patients.
    Meunier F; Paesmans M; Autier P
    Eur J Cancer B Oral Oncol; 1994 May; 30B(3):196-9. PubMed ID: 7920166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candida esophagitis in two children with acute leukemia: successful therapy with ketoconazole.
    Rao SP; Hammerschlag MR; Walk JA
    Am J Pediatr Hematol Oncol; 1985; 7(3):308-11. PubMed ID: 3865555
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.